Pacific Biosciences of California, Inc.
PACB
|
$1.55
6.16%
5.81%
17M
|
Health Technology
(0.0% 1d) (-63.4% 1m) (-87.3% 1y) (0.0% 2d) (0.0% 3d) (-55.1% 7d) (-45.91% volume)
Earnings Calendar: 2024-02-15
Market Cap: $ 415,325,414
http://www.pacb.com
Sec Filling | Patents | 404 employees
Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.
genetic
add to watch list Paper trade email alert is off
Press-releases
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
Published: 2024-04-16 (Crawled : 12:00) - prnewswire.com
PACB | $1.55 6.16% 5.81% 17M
|
Health Technology
|
| O: -37.5%
H: 3.08%
C: -28.21%
first revenue
DNA Methylation Detection Technology Markets, 2033 - Intensified Competition, Increasing Adoption, PCR Dominates
Published: 2024-03-30 (Crawled : 04:20) - prnewswire.com
ABCM | $23.99 0.0% 7.4M
|
Health Technology
| Email alert
Add to watchlist
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
| Email alert
Add to watchlist
HOLX | $75.37 0.36% 0.36% 1.3M
|
Health Technology
| Email alert
Add to watchlist
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
| Email alert
Add to watchlist
PACB | $1.55 6.16% 5.81% 17M
|
Health Technology
| Email alert
Add to watchlist
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
| Email alert
Add to watchlist
A | $132.73 0.22% 0.0% 1.3M
|
Health Technology
| Email alert
Add to watchlist
BIO | $279.73 -0.46% 0.0% 290K
|
Health Technology
| Email alert
Add to watchlist
PKI | $115.24 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
| Email alert
Add to watchlist
ABCZF | $22.1 -2.32% 4K
|
Health Technology
| Email alert
Add to watchlist
dna technology
PacBio Grants Equity Incentive Award to New Employee
Published: 2024-03-22 (Crawled : 21:00) - prnewswire.com
PACB | $1.55 6.16% 5.81% 17M
|
Health Technology
| Email alert
Add to watchlist
award grants employee
PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions
Published: 2024-03-12 (Crawled : 13:00) - prnewswire.com
PACB | $1.55 6.16% 5.81% 17M
|
Health Technology
|
| O: -0.68%
H: 1.14%
C: -8.24%
expansion research solutions
PacBio to Present at Upcoming Investor Conferences
Published: 2024-02-26 (Crawled : 21:00) - prnewswire.com
PACB | $1.55 6.16% 5.81% 17M
|
Health Technology
|
| O: 2.29%
H: 6.36%
C: 5.05%
Experiential Marketing Firm VOLO Events Agency Wins Best Event Technology Award for PacBio Product Launch
Published: 2024-02-13 (Crawled : 12:00) - prnewswire.com
PACB | $1.55 6.16% 5.81% 17M
|
Health Technology
|
| O: -7.3%
H: 2.57%
C: -2.25%
award technology
Europe Next Generation Sequencing (NGS) Market Report 2023-2033: Evolving Regulatory Landscape for Clinical NGS and Growing Number of Gene Mutations across Various Diseases Present Opportunities
Published: 2024-02-06 (Crawled : 20:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: 0.31%
H: 0.71%
C: -1.72%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -1.25%
H: 0.07%
C: -1.63%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -1.25%
H: 0.07%
C: -1.63%
PACB | $1.55 6.16% 5.81% 17M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: -4.1%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: -1.48%
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: -3.4%
H: 9.54%
C: 9.43%
europe report growing market
PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale
Published: 2024-02-05 (Crawled : 14:00) - prnewswire.com
PACB | $1.55 6.16% 5.81% 17M
|
Health Technology
|
| O: -3.26%
H: 2.6%
C: -1.38%
PacBio to Report Fourth Quarter 2023 Financial Results on February 15, 2024
Published: 2024-01-25 (Crawled : 21:00) - prnewswire.com
PACB | $1.55 6.16% 5.81% 17M
|
Health Technology
|
| O: 1.55%
H: 4.02%
C: -2.64%
report financial results
PacBio Announces New Nanobind PanDNA Kit Enabling HiFi Optimized DNA Extraction Solutions
Published: 2024-01-15 (Crawled : 14:00) - prnewswire.com
PACB | $1.55 6.16% 5.81% 17M
|
Health Technology
| Email alert
Add to watchlist
solutions enabling dna
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M
|
n/a
|
23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M
|
Finance
|
22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
22:30
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
22:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10